entertainment -WSS

entertainment

author：leisure time 2025-09-30 18:21:33 - browse：12559

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

focus

WSS

For BCIs, commercial hurdles may be bigger than scientific ones

BIO selects John Crowley as new CEO

Flagship Pioneering launches a new biotech in two countries

With clinical trial data readouts, here's how to spot spin

Pediatric cancer treatments threatened by a new FDA policy

Fetal surgery at risk from Dobbs and new abortion restrictions

focus

entertainment

focus

Apple is now the first public company to be valued at $3 trillion

Rep. Raul Ruiz on the physician shortage and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Attacks on the drug industry will lead to fewer breakthroughs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Hepatitis C has a cure — but many Americans still lack access to it

Stem cell clinics for heart failure: buyer be wary

DIEP, the 'gold standard' of breast reconstruction, is under threat

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

knowledge

ER docs worry over extreme heat as a 'mass casualty event'

Biden calls for immediate release of Niger's president amid apparent coup

The EPA's new lead rule: How one expert crunched the numbers

Mayo Clinic plans $5B tech

U.K. Biobank has 500,000 peoples' genome sequences available

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

focus

entertainment

focus

knowledge